Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1Pfizer CentreOne
03 1HUASHU PHARMACEUTICAL CORPORATION
04 1Merck & Co
05 3Pfizer Inc
06 3Siegfried AG
07 1Yichang Sanxia Pharmaceutical Co., Ltd.
01 1NEOMYCIN PALMITATE
02 4NEOMYCIN SULFATE
03 1NEOMYCIN SULFATE (VET MED)
04 1NEOMYCIN SULFATE 0.5GM, COMMERICIAL GRADE, NOT USP
05 1NEOMYCIN SULFATE AND NEOMYCIN SULFATE MICRONIZED
06 1NEOMYCIN SULFATE CAPS (THIS DMF CHANGED TO NDA 9-579)
07 2NEOMYCIN SULFATE USP
01 2China
02 1France
03 3Switzerland
04 5U.S.A
01 3Active
02 8Inactive
01 1Complete
02 10Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13615
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-26
Pay. Date : 2013-02-13
DMF Number : 13378
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17382
Submission : 2004-05-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 271
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 270
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 262
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 124
Submission : 1953-07-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 264
Submission : 1957-07-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 110
Submission : 1953-05-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32091
Submission : 2017-09-08
Status : Active
Type : II
A Neomycin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neomycin Sulfate, including repackagers and relabelers. The FDA regulates Neomycin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neomycin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Neomycin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Neomycin Sulfate supplier is an individual or a company that provides Neomycin Sulfate active pharmaceutical ingredient (API) or Neomycin Sulfate finished formulations upon request. The Neomycin Sulfate suppliers may include Neomycin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Neomycin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Neomycin Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Neomycin Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Neomycin Sulfate DMFs exist exist since differing nations have different regulations, such as Neomycin Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Neomycin Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Neomycin Sulfate USDMF includes data on Neomycin Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Neomycin Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Neomycin Sulfate suppliers with USDMF on PharmaCompass.
We have 7 companies offering Neomycin Sulfate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?